SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-006860
Filing Date
2022-05-02
Accepted
2022-05-02 16:05:01
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dyn-20220331.htm   iXBRL 10-Q 2354667
2 EX-31.1 dyn-ex31_1.htm EX-31.1 14652
3 EX-31.2 dyn-ex31_2.htm EX-31.2 15728
4 EX-32.1 dyn-ex32_1.htm EX-32.1 7421
5 EX-32.2 dyn-ex32_2.htm EX-32.2 7328
  Complete submission text file 0000950170-22-006860.txt   7352087

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dyn-20220331_lab.xml EX-101.LAB 387858
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dyn-20220331_cal.xml EX-101.CAL 47735
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dyn-20220331_def.xml EX-101.DEF 122278
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dyn-20220331.xsd EX-101.SCH 46258
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dyn-20220331_pre.xml EX-101.PRE 288951
53 EXTRACTED XBRL INSTANCE DOCUMENT dyn-20220331_htm.xml XML 1301865
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39509 | Film No.: 22881879
SIC: 2834 Pharmaceutical Preparations